| Revenue growth | Standalone +9% YoY, Consolidated +13% YoY. |
|---|---|
| Margins | Margins impacted by raw materials; expected to improve with capacity utilization. |
| Order book | Initial orders secured for GEM Cool 03, 05, and 23. |
| Demand visibility | Progressing customer engagement and product qualification. |
| Management confidence | High on monetising Dahej platform and scaling new categories. |
Growth
Standalone Revenue: Rs 83.0 Cr (+9% YoY); Consolidated Revenue: Rs 98.9 Cr (+13% YoY). Consolidated PAT fell 199% due to high depreciation.
Outlook
Planned capex of ~Rs 270 Cr at Dahej nearly complete. New cooling agent and safranal revenue expected from Q3FY27.
Risks
Clove business impacted by Madagascar floods; higher raw material costs and product mix hit margins. Rs 9.1 Cr depreciation impact.
Last quarter's promises, checked
Delivered
- Guided Dahej capex ~Rs 270 Cr → delivered Rs 265 Cr capitalized (= BEAT)
- Guided commercial production of Gemcool 5/Safranal → delivered production commenced (= BEAT)
Partly delivered
- Guided ramp-up of Dahej facility → delivered initial orders for GEM Cool series (= PARTIAL)
Missed
- Guided consolidated revenue growth → delivered Rs 98.9 Cr (sequential decline from Rs 110 Cr) (= MISS)
Investor Presentation filed with BSE, NSE: GEMAROMA. Summary written with AI assistance from the document.
Gem Aromatics Ltd: key numbers
- Share price
- ₹158.93
- Market cap
- ₹830.2 Cr
- Revenue (annual)
- ₹366.5 Cr
- Net profit (annual)
- ₹1.42 Cr
- P/E (TTM)
- -57.5×Sector 37.5×
- Promoter holding
- 57.45%+0.44% QoQ
- FII holding
- 0.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gem Aromatics Ltd
All →Gem Aromatics Acquisition Worth ₹225.2 Cr
Gem Aromatics Limited is acquiring Krystal Ingredients Private Limited for ₹225.21 Crore through the conversion of a loan into equity.
- Value
- ₹225.2 Cr
Gem Aromatics Acquisition
Gem Aromatics Limited approved converting existing inter-company loans into equity shares of its wholly-owned subsidiary, Krystal Ingredients Private Limited, to strengthen the subsidiary's capital base.
- Execution
- Within one month from receipt of requisite approvals
Gem Aromatics Annual Report
The company submitted a revised Annual Report for FY 2025-26, replacing inadvertently attached unfinalized annexures. No content changes were made to the report.
Gem Aromatics Q1 FY27 Results: Net Loss of ₹7.9 Cr
Gem Aromatics Ltd reported revenue from operations of ₹98.8 Cr (+12.8% YoY) and a net loss of ₹7.9 Cr for Q1 FY27.
- Key figure
- Net loss ₹7.9 Cr
Gem Aromatics Earnings Call: Key Takeaways
Gem Aromatics reports Q4 FY26 sequential recovery with consolidated revenue of ₹110cr (up 40% QoQ). Strategy focuses on diversifying from mint into high-margin clove derivatives and cooling agents via the new Dahej facility.
Gem Aromatics Earnings Call: Key Takeaways
Gem Aromatics reports sequential recovery in Q4FY26 with revenue of ₹110 Cr (Consolidated). Focus is on ramp-up at the greenfield Dahej facility and higher-value specialty molecules.